World Veterinary Health Products (Animal Pharmaceuticals, Vaccines, OTC and Performance Enhancers)

$995 – $7,000

Clear
SKU: KLI1829596 Category: Pages: 160

Published on: May 1, 2009

Description

The multi-billion veterinary health products market, though smaller in opportunity as compared with the human health sector, offers significant return on investment, primarily driven by lower risk and faster product development cycles. The veterinary health products market has remained resilient over the economic downturns of the past 2 decades.

This report, World Veterinary Health Products, takes a look at veterinary health products for both companion (pet) animals, and production animals (livestock and poultry) and the opportunity for existing players and new entrants in three segments:

  • Pharmaceuticals (including Parasiticides, Anti-infectives, NSAIDS, Cardiovasculars, Hormones, CNS, Others)
  • Veterinary (Pet) OTC Products
  • (Parasiticides, NSAIDS, Vitamins, GI Disorders, Cold and Cough, Others)
  • Performance Enhancers
  • Veterinary Vaccines

For each segment, the report includes pet and production animal demographic information, market forecasts to 2014, major products in the industry, trends affecting business planning, and competitive activity. Revenues are provided for U.S., Europe and Rest of World.
This report profiles the following key companies in this industry:
This report profiles the following key companies in this industry:

 

  • Alpharma Animal Health
  • Adisseo France S.A.S.
  • BASF International
  • Bayer Healthcare
  • Boehringer Ingelheim GmbH
  • DSM Nutritional Products, Inc.
  • Elanco Animal Health
  • Fort Dodge Animal Health
  • Heska Corporation
  • Intervet Schering Plough Animal Health
  • Merial Animal Health Ltd.
  • Novartis Animal Health Inc.
  • Virbac SA
  • Pfizer Animal Health

 

 

This report was constructed with secondary research into annual reports, government health data, trade and medical journals, supplemented with phone and email interviews with executives and experts in the industry. Interviews were used to test assumptions and fix forecasts in the report.

Table of Contents

CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET- STRATEGIC PERSPECTIVES

1.1. A Resilient Market, Even in Downturns

1.2. Epidemiology

Livestock

Pets

1.3. Veterinary Health Products Industry Structure

1.3.1. Key Factors Affecting the Industry

  1. a) Threat of Generics
  2. b) Lack of innovation
  3. c) Expectations
  4. d) High dependence on the product

1.4. Market

1.5. Market Segments

1.5.1 Companion Animal Products (CAP)

  1. a) Pet Insurance Market

1.5.2. Food Animal Products (FAP)

  1. a) Leading Growth Drivers

1.6. Customer Segments

  1. a) Veterinary Hospitals
  2. b) Farms
  3. c) Pet Owners

1.7. Market Size and Growth

1.8. Market Segments

1.8.1. Veterinary Pharmaceuticals Market

1.8.2. Veterinary Vaccines Market

1.8.3. Veterinary Performance Enhancers Market

1.9. Geography

1.10. Species

1.11. Competition

1.12. Mergers and Acquisitions

1.13. Research and Development

  1. a) Leading R&D trends in the Animal Health Industry

1.14. Future Industry trends for Growth

  1. a) Shift from product to market focus
  2. b) Enhanced focus on R&D
  3. c) Consolidation and Globalization

 

CHAPTER TWO: VETERINARY PHARMACEUTICAL PRODUCTS MARKET

2.1. Background

  1. a) Preventative medicines
  2. b) Therapeutic Medicines
  3. c) Others

2.2. Market Size and Growth

2.3. Market Segments

2.3.1. Veterinary Anti-Infective Market

2.3.2. Veterinary Anti-inflammatory Products Market

2.3.3. Veterinary Cardiovascular Products Market

2.3.4. Veterinary Parasiticidal Products Market

2.3.5. Veterinary CNS disorders Products Market

2.3.6. Veterinary Hormonal Products Market

2.4. Competition

2.5. Leading Market Trends

  1. a) Generics threat
  2. b) New technologies and innovations
  3. c) New geographical market growth

 

CHAPTER THREE: VETERINARY VACCINES MARKET

3.1. Background

3.2. Veterinary Diseases & Vaccination

3.2.1. Vaccine Types

  1. a) Live vaccines
  2. b) Dead vaccines

3.2.2. Livestock Vaccination

  1. a) Cattle Vaccines
  2. b) Sheep Vaccines
  3. c) Goat Vaccines
  4. d) Pig Vaccines
  5. e) Swine Vaccines

3.2.3. Pet vaccines

  1. a) Background
  2. b) Current guidelines

3.2.4. Poultry vaccines

3.3. Vaccination Advantages

  1. a) Cost containment
  2. b) Reduction in antibiotic use
  3. c) Improvement in human health
  4. d) Impact on the industry
  5. e) Good Health, consistent throughput

3.4. Disease costs

3.5. Vaccine development

  1. a) Development Process
  2. b) Equipment

3.6. Vaccination Guidelines

3.7. Market Size and Growth

3.8. Geographical split

3.9. Competitive Share

  1. a) Demand Drivers: Positive Factors
  2. b) Demand: Negative Factors

3.10. Hurdles in Vaccine Development

  1. a) Biological and technical obstacles
  2. b) Economic obstacles
  3. c) Target complexity and diversity

3.11. Regulatory Aspects

3.12. International Cooperation on Harmonization Guidelines for Vaccines

3.13. Procedures for licensing veterinary vaccines

  1. a) Japan
  2. b) United States of America
  3. c) European Union

3.14. Future Trends

  1. a) Emerging diseases
  2. b) New vaccine technologies

 

CHAPTER FOUR: VETERINARY PERFORMANCE ENHANCERS PRODUCTS MARKET

4.1. Background

4.2. Feed Additives

4.2.1. Feed Composition

4.2.2. Nutritional Feed Additives

  1. a) Amino acids
  2. b) Vitamins
  3. c) Organic acids

4.2.3. Medicated Feed Additives

  1. a) Enzymes
  2. b) Prebiotics, Probiotics
  3. c) Hormones

4.2.4. Feed Additives: Advantages

  1. a) Improve animal diet.
  2. b) Provide therapeutic benefit and reduce cost.
  3. c) Increase feed conversion efficiency thereby leading to improved profitability.

4.3. Market size and growth

4.3.1. Market Growth Drivers

4.4. Market Segments

4.4.1. Nutritional Feed Additives Market

  1. a) Amino acids
  2. b) Vitamins
  3. c) Organic Acids

4.4.2. Medicated Feed Additives Market

  1. a) Antibiotics
  2. b) Probiotics and Prebiotics
  3. c) Enzymes
  4. d) Anti-protozoal agents

4.4.2.1. Medicated Feed Additives: By Species (Poultry, Pigs, Cattle, Others), 2008

4.5. Geographical Split

4.6. Competition

4.7. Implants and Injections

4.7.1. Market Size and Growth

4.8. Regulatory Framework

  1. a) US
  2. b) Europe

4.9. Safety Issues

 

CHAPTER FIVE: VETERINARY OTC PRODUCTS MARKET

5.1. Background

5.2. Pet population trends

  1. a) Greying human populace
  2. b) Increasing life expectancy of pets
  3. c) Advantages

5.3. Market Size and Growth

5.4. Market Segments

5.5. Market Drivers

  1. a) Rising pet ownership
  2. b) Consumer behavior
  3. c) Rx-to-OTC switch
  4. d) Product quality
  5. e) Price sensitivity
  6. f) Improving distribution network
  7. g) Increasing focus on Wellness

5.6. Product Life-cycle Management

  1. a) Broad customer group
  2. b) New formulations
  3. c) Creative marketing strategies
  4. d) Distribution Structure

5.7. Regulatory Issues

 

CHAPTER SIX: CORPORATE PROFILES

6.1. Alpharma Animal Health

Background

Products

Revenues

Business Strategy

6.2. Adisseo France S.A.S.

Background

Products

Business Strategy

Revenues

6.3. BASF International

Background

Products

Revenues

6.4. Bayer Healthcare

Background

Products

Revenues

6.5. Boehringer Ingelheim GmbH

Background

Products

Revenues

6.6. DSM Nutritional Products, Inc.

Background

Products

Revenues

6.7. Elanco Animal Health

Background

Products

Revenues

6.8. Fort Dodge Animal Health

Background

Products

Revenues

6.9. Heska Corporation

Background

Products

Revenue

6.10. Intervet Schering Plough Animal Health

Background

Products

Products

Revenues

6.11. Merial Animal Health Ltd.

Background

Products

Revenues

6.12. Novartis Animal Health Inc.

Background

Products

Farm animal products

Livestock animal products

6.13. Virbac SA

Background

Revenues

Products

6.14. Pfizer Animal Health

Background

Products

Revenues

LIST OF EXHIBITS

CHAPTER ONE: VETERINARY HEALTH PRODUCTS MARKET STRATEGIC PERSPECTIVES

Exhibit 1: Worldwide Livestock Population, 2008

Exhibit 2: Worldwide Pet population, 2008

Exhibit 3: Market Share: Companion Animal vs. Food Production Animal

Exhibit 4: Worldwide Companion Animal Prescriptions and Vaccines Market, 2008

Exhibit 5: US Household Penetration of Pets (%), 2008

Exhibit 6: Worldwide Veterinary Health Products Market

Exhibit 7: Worldwide Veterinary Health Products Market: Market Segments ($ billion) and Growth (%) (2006-14)

Exhibit 8: Worldwide Veterinary Health Products Market:

Exhibit 9: Worldwide Veterinary Pharmaceuticals Market:

Exhibit 10: Worldwide Veterinary Pharmaceutical Products Market, 2006-14

Exhibit 11: Worldwide Veterinary Vaccines Market:

Exhibit 12: Veterinary Vaccines Market, 2006-14

Exhibit 13: Worldwide Veterinary Performance Enhancer Products Market:

Exhibit 14: Veterinary Performance Enhancers Market, 2006-14

Exhibit 15: Regional Share Break-up (%), 2008

Exhibit 16: Worldwide Veterinary Health Products Market:

Exhibit 17: Worldwide Veterinary Health Products Market by Region:

Exhibit 18: Veterinary Health Products Market by Species, 2008 (Ruminants, Pigs, Poultry, Companions, Others)

Exhibit 19: Veterinary Health Products Market: Leading Companies, 2008

Exhibit 20: Veterinary Health Products Industry: Mergers and Acquisitions Trends

CHAPTER TWO: VETERINARY PHARMACEUTICAL PRODUCTS MARKET

Exhibit 21: Veterinary Pharmaceutical Products Market, 2006-14 (US, Europe, ROW)

Exhibit 22: Veterinary Pharmaceutical Products Market, 2006-14 (US, Europe, ROW)

Exhibit 23: Veterinary Pharmaceutical Products Market, 2006-14 (Parasiticides, Anti-infectives, NSAIDS, Cardiovasculars, Hormones, CNS, Others)

Exhibit 24: Veterinary Pharmaceutical Products Market: Segment Share %, 2008

Exhibit 25: Generic vs. Branded Products 2008

Exhibit 26: Veterinary Anti-infective Products Market by Region (US, Europe, ROW), 2006-14

Exhibit 27: Veterinary Anti-inflammatory Products Market by Region (US, Europe, ROW), 2006-14

Exhibit 28: Veterinary Cardiovascular Products Market by Region (US, Europe, ROW), 2006-14

Exhibit 29: Veterinary Parasiticidal Products Market Veterinary Implants Market by Region (US, Europe, ROW), 2008-14

Exhibit 30: Veterinary CNS Disorders Products Market by Region (US, Europe, ROW), 2006-14

Exhibit 31: Veterinary Hormone Products Market by Region (US, Europe, ROW), 2006-14

Exhibit 32: Veterinary Pharmaceutical Products Market Share

CHAPTER THREE: VETERINARY VACCINES MARKET

Exhibit 33: Trade of Livestock in Millions of Tons (Beef, Pork, Poultry) 2001-2014

Exhibit 36: Disease Outbreak: Direct versus Indirect cost comparison

Exhibit 34: Veterinary Vaccines Market by Region (US, Europe, ROW), 2006-14

Exhibit 35: Veterinary Vaccines Market by Region (US, Europe, ROW), 2006-14

Exhibit 36: Veterinary Vaccines Market by Region (USA, Europe, ROW)

Exhibit 37: Veterinary Vaccine Sales by Species (Livestock, Poultry, Other)

Exhibit 38: Veterinary Vaccines, Competitive Share, 2008

CHAPTER FOUR: VETERINARY PERFORMANCE ENHANCERS PRODUCTS MARKET

Exhibit 40: Veterinary Performance Enhancers Market, 2006-14

Exhibit 41: Veterinary Performance Enhancers: Segment Share(Medicated Feed Additives, Nutritional Feed Additives, Implants and Injections), 2008

Exhibit 42: Worldwide Nutritional Feed Additives Market(Amino Acids, Vitamins, Organic Acids), 2006-14

Exhibit 43: Veterinary Nutritional Feed Additives: Segment Share, 2008

Exhibit 44: Worldwide Medicated Feed Additives Market (Antibiotics, Enzymes, Probiotics and Prebiotics, Anti-protozoals), 2006-14

Exhibit 45; Worldwide Medicated Feed Additives: Segment Share, 2008

Exhibit 46: Veterinary Performance Enhancers Market, Competitive Share, 2008

Exhibit 47: Veterinary Feed Additives Market by Geography (US, Europe, ROW), 2008

Exhibit 48: Veterinary Performance Enhancers Market, Competitive Share, 2008

Exhibit 49: Veterinary Implants Market by Region (US, Europe, ROW), 2006-14

Exhibit 50: Veterinary Implants Market by Region (US, Europe, ROW), 2006-14

CHAPTER FIVE: VETERINARY OTC PRODUCTS MARKET

Exhibit 51: Pet Population (Dogs, Cats Rabbits, Horses) by Region (US, Europe, Global) 2008

Exhibit 52: Veterinary OTC Health Products Market, 2006-14

Exhibit 53:Veterinary OTC Health Products Market

Exhibit 54: Veterinary OTC Health Products Market by Segments (Parasiticides, NSAIDS, Vitamins, GI Disorders, Cold and Cough, Others) 2006-14

Exhibit 55: US Household Pet Ownership (Dogs, Cats, Birds, Horses)

 

Pharmaceutical Markets in India World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The
Register for Access Login for Access

Register for Access Login for Access

Lost your password? Register